Skip to the page

Data / Form D filings / Sonablate Corp.

Sonablate Corp.: Form D filing

Sonablate Corp., a biotechnology company in Charlotte, NC, filed a Form D with the SEC in 2023. The latest, on August 3, 2023, reports $377,000 sold of a $60 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10130 Perimeter Parkway, Suite 410, Charlotte, NC, 28226
Phone
(704) 817-1176
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1987408

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 3, 2023New notice$60,000,000$377,000$59,623,0006Jul 12, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Thomas MendellDirector
Ralph SeipExecutive Officer
Louis TaExecutive Officer
Richard YangExecutive Officer, Director
Hong WeiDirector
Neal SanganiDirector
Alejandro GonzalezExecutive Officer, Director
Bruce MurphyDirector
Samuel PeretsmanDirector

Other biotechnology companies in North Carolina that filed recently

Every Form D from the week of Jul 31, 2023 · All recent filings in North Carolina · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Sonablate Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.